(1 - 11 from 25
)
89Bio Launches into Liver and Metabolic Disorders with $ www.finanzen.ch › News & Analysen › News
www.finanzen.ch
Rohan Palekar joins as CEO. About NASH NASH is the most advanced stage of nonalcoholic fatty liver disease (NAFLD). It is a complex ...
Avanir’s Onzetra Xsail intranasal sumatriptan approved by FDA
www.oindpnews.com
Commenting on the approval, newly appointed Avanir President and CEO Rohan Palekar said, “We are excited about this major milestone for Avanir as the ...
Investigative NASH therapy BIO shows improved lipid ...www.healio.com › steatohepatitis-metabolic-liver-disease › news › online
www.healio.com
... address the complex nature of NASH, especially in patients with metabolic comorbidities,” Rohan Palekar, CEO of 89Bio, said in the release.
sorted by relevance / date